BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 14614651)

  • 1. TIPS implantation raises leptin levels in patients with liver cirrhosis.
    Nolte W; Wirtz M; Rossbach C; Leonhardt U; Buchwald AB; Scholz KH; Ramadori G
    Exp Clin Endocrinol Diabetes; 2003 Oct; 111(7):435-42. PubMed ID: 14614651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum leptin levels in alcoholic liver cirrhosis: relationship with gender, nutritional status, liver function and energy metabolism.
    Campillo B; Sherman E; Richardet JP; Bories PN
    Eur J Clin Nutr; 2001 Nov; 55(11):980-8. PubMed ID: 11641747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ascites resolution after successful TIPS on nutrition in cirrhotic patients with refractory ascites.
    Allard JP; Chau J; Sandokji K; Blendis LM; Wong F
    Am J Gastroenterol; 2001 Aug; 96(8):2442-7. PubMed ID: 11513188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum zinc, plasma ghrelin, leptin levels, selected biochemical parameters and nutritional status in malnourished hemodialysis patients.
    Sahin H; Uyanik F; Inanç N; Erdem O
    Biol Trace Elem Res; 2009 Mar; 127(3):191-9. PubMed ID: 18953507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in body composition after transjugular intrahepatic portosystemic stent in cirrhosis: a critical review of literature.
    Dasarathy J; Alkhouri N; Dasarathy S
    Liver Int; 2011 Oct; 31(9):1250-8. PubMed ID: 21745273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in adipokines after transjugular intrahepatic porto-systemic shunt indicate an anabolic shift in metabolism.
    Thomsen KL; Sandahl TD; Holland-Fischer P; Jessen N; Frystyk J; Flyvbjerg A; Grønbæk H; Vilstrup H
    Clin Nutr; 2012 Dec; 31(6):940-5. PubMed ID: 22541535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
    Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
    Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis.
    Lotterer E; Wengert A; Fleig WE
    Hepatology; 1999 Mar; 29(3):632-9. PubMed ID: 10051460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites.
    Alam I; Bass NM; Bacchetti P; Gee L; Rockey DC
    Am J Gastroenterol; 2000 Jan; 95(1):199-203. PubMed ID: 10638583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal plasma peptide YY(3-36) levels in patients with liver cirrhosis.
    Valentini L; Schuetz T; Omar A; Gläser S; Kasim E; Nowotny P; Kroencke T; Ockenga J
    Nutrition; 2011 Sep; 27(9):880-4. PubMed ID: 21819934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic and intestinal cytochrome P450 3A activity in cirrhosis: effects of transjugular intrahepatic portosystemic shunts.
    Chalasani N; Gorski JC; Patel NH; Hall SD; Galinsky RE
    Hepatology; 2001 Dec; 34(6):1103-8. PubMed ID: 11731998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of leptin concentration to gender, body mass index and age in Saudi adults.
    Al-Harithy RN
    Saudi Med J; 2004 Aug; 25(8):1086-90. PubMed ID: 15322603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A low pretransplant peripheral blood mononuclear cell complex I activity predicts metabolic disturbances and inability to regain fat free mass in cirrhotic patients undergoing liver transplantation.
    Briet F; Aqel BA; Jeejeebhoy KN; Scolapio JS
    Nutr Res; 2009 Jan; 29(1):26-34. PubMed ID: 19185774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.
    Kim JJ; Dasika NL; Yu E; Fontana RJ
    J Clin Gastroenterol; 2009 Jul; 43(6):574-9. PubMed ID: 19169145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurophysiological evidence of cognitive impairment in patients without hepatic encephalopathy after transjugular intrahepatic portosystemic shunts.
    Kramer L; Bauer E; Gendo A; Funk G; Madl C; Pidlich J; Gangl A
    Am J Gastroenterol; 2002 Jan; 97(1):162-6. PubMed ID: 11808942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum leptin levels in female patients with protein-calorie malnutrition and its relation to biochemical indicators of nutritional status].
    Haluzík M; Kábrt J; Nedvídková J; Svobodová J; Kotrlíková E
    Vnitr Lek; 1999 Apr; 45(4):202-5. PubMed ID: 11045179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum leptin levels in patients with nonalcoholic chronic liver disease.
    Nakamuta M; Tada S; Uchimura K; Enjoji M; Kinukawa N; Iwamoto H; Sugimoto R; Shimada M; Ohashi M; Sugimachi K; Nawata H
    Hepatogastroenterology; 2001; 48(38):527-32. PubMed ID: 11379347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of infectious complications after transjugular intrahepatic portosystemic shunt in cirrhotic patients with a single dose of ceftriaxone.
    Gulberg V; Deibert P; Ochs A; Rossle M; Gerbes AL
    Hepatogastroenterology; 1999; 46(26):1126-30. PubMed ID: 10370679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated leptin fragments in renal failure correlate with BMI and haematopoiesis and are normalized by haemodialysis.
    Stamatiadis DN; Chan JL; Cogswell R; Stefanopoulou HC; Bullen J; Katsilambros N; Stathakis CP; Mantzoros CS
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):434-41. PubMed ID: 15049957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.